Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Elevance Health, Inc.

Stage 2 · Advancing · week 6

As of Oct 22, 2026, Elevance Health is in Stage 2, the uptrend phase, now in week 6 (since Sep 17, 2026). It closed at $445.28, at its 52-week high and above its 200-day average, which is rising.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. More about the company

$445.28
+2.49% today
$96.6B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Early entry: still early enough in its move

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 5 in Healthcare Plans · #1 of 272 in Health Care

Is ELV early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 34w
S4 19w
S4 19w
S1 15w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 8w → S4 6w → S1 2w → S2 34w → S3 5w → S2 6w → S3 2w → S4 19w → S1 11w → S4 19w → S1 15w → S2 6w → S3 3w → S4 6w → S1 1w → S2 13w → S3 4w → S2 5w current
Total tracked: 165 weeks across 18 stage runs.

ELV among Healthcare Plans6th of 11 by relative strength

All 11 →
Stocks in Healthcare Plans ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CNCStage 2 · wk 194+14.8%
2OSCRStage 2 · wk 2287+9.1%
3PGNYStage 3 · wk 786+12.7%
4CLOVStage 2 · wk 285+3.5%
5HUMStage 2 · wk 284+12.3%
6ELVStage 2 · wk 676+11.7%
7UNHStage 3 · wk 769+14.5%
8CVSStage 3 · wk 768+10.8%
vs 52W High
0.0%
$276.69 lo$445.28 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 6
1w13w26w
Week 6, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
20.9%
200 DMA: $368.27 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.24x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+11.7%
3M
+18.4%
6M
+29.7%
YTD
+27.5%
1Y
+29.8%
Scan Membership
Breakout Watch
Latest: 2024-08-30
12 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 6 · Vol 1.24x
2026-10-21S2
Wk 5 · Vol 1.86x
2026-10-20S2
Wk 5 · Vol 1.39x
2026-10-19S2
Wk 5 · Vol 0.90x
2026-10-16S2
Wk 5 · Vol 1.10x
2026-10-15S2
Wk 5 · Vol 1.38x
2026-10-14S2
Wk 4 · Vol 1.95x
2026-10-13S2
Wk 4 · Vol 1.72x
2026-10-12S2
Wk 4 · Vol 0.81x
2026-10-09S2
Wk 4 · Vol 1.98x
2026-10-08S2
Wk 4 · Vol 0.74x
2026-10-07S2
Wk 3 · Vol 0.84x
Moving averages & range
50 DMA
$406.56
200 DMA
$368.27
52W High
$445.28
52W Low
$276.69
5D Low
$428.26
Resistance levels (recent highs)
20d High
$445.28
60d High
$445.28
120d High
$445.28
250d High
$445.28
Next resistance
Above all
P/E (TTM)
18.9
Forward 14.8
Earnings Growth (YoY)
-13.1%
Revenue +1.4%
ROE
+11.1%
Profit margin +2.5%
Dividend Yield
1.58%
P/B 2.2

Elevance Health: quick answers

What stage is Elevance Health in?

As of Oct 22, 2026, Elevance Health (ELV) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 17, 2026 and is in week 6. What the four stages mean

Is Elevance Health in an uptrend?

Yes. Elevance Health is in a Stage 2 uptrend. It trades 20.9% above its 200-day average, which is rising.

How far is Elevance Health from its 52-week high?

Elevance Health closed at $445.28 on Oct 22, 2026, at its 52-week high. Its 52-week low is $276.69.

How has Elevance Health performed over the past year?

As of Oct 22, 2026, Elevance Health is up 29.8% over the past year and up 27.5% so far in 2026.

Which sector and industry is Elevance Health in?

Elevance Health is in the Healthcare Plans industry, part of the Health Care sector.

About this companyHealth Care· Healthcare Plans

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.